Trexquant Investment’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,916
| Closed | -$6.42M | – | 1596 |
|
|
2025
Q1 | $6.42M | Buy |
37,916
+17,749
| +88% | +$2.92M | 0.07% | 410 |
|
|
2024
Q4 | $3.04M | Buy |
+20,167
| New | +$3.14M | 0.04% | 701 |
|
|
2024
Q3 | – | Sell |
-77,011
| Closed | -$10.5M | – | 1597 |
|
|
2024
Q2 | $10.5M | Buy |
77,011
+48,274
| +168% | +$6.61M | 0.16% | 172 |
|
|
2024
Q1 | $3.83M | Buy |
28,737
+18,054
| +169% | +$2.34M | 0.08% | 404 |
|
|
2023
Q4 | $1.47M | Buy |
+10,683
| New | +$1.4M | 0.03% | 677 |
|
|
2022
Q4 | – | Sell |
-72,834
| Closed | -$8.94M | – | 1437 |
|
|
2022
Q3 | $8.94M | Buy |
72,834
+45,330
| +165% | +$5.97M | 0.31% | 70 |
|
|
2022
Q2 | $3.66M | Buy |
27,504
+2,640
| +11% | +$360K | 0.16% | 143 |
|
|
2022
Q1 | $3.4M | Buy |
24,864
+23,476
| +1,691% | +$3.27M | 0.16% | 157 |
|
|
2021
Q4 | $240K | Sell |
1,388
-774
| -36% | -$118K | 0.01% | 1043 |
|
|
2021
Q3 | $314K | Sell |
2,162
-9,957
| -82% | -$1.46M | 0.02% | 719 |
|
|
2021
Q2 | $1.6M | Sell |
12,119
-1,835
| -13% | -$240K | 0.13% | 209 |
|
|
2021
Q1 | $1.79M | Buy |
13,954
+5,122
| +58% | +$631K | 0.16% | 168 |
|
|
2020
Q4 | $1.05M | Buy |
8,832
+1,669
| +23% | +$203K | 0.11% | 247 |
|
|
2020
Q3 | $820K | Sell |
7,163
-4,268
| -37% | -$504K | 0.05% | 483 |
|
|
2020
Q2 | $1.3M | Buy |
+11,431
| New | +$1.21M | 0.09% | 316 |
|
|
2020
Q1 | – | Sell |
-4,971
| Closed | -$531K | – | 1182 |
|
|
2019
Q4 | $531K | Buy |
+4,971
| New | +$518K | 0.03% | 543 |
|
|
2019
Q3 | – | Sell |
-15,511
| Closed | -$1.58M | – | 911 |
|
|
2019
Q2 | $1.58M | Buy |
+15,511
| New | +$1.49M | 0.14% | 214 |
|
|
2018
Q4 | – | Sell |
-41,046
| Closed | -$4.43M | – | 1080 |
|
|
2018
Q3 | $4.43M | Buy |
41,046
+35,493
| +639% | +$3.89M | 0.33% | 80 |
|
|
2018
Q2 | $610K | Sell |
5,553
-5,982
| -52% | -$623K | 0.04% | 485 |
|
|
2018
Q1 | $1.16M | Sell |
11,535
-23,075
| -67% | -$2.36M | 0.08% | 377 |
|
|
2017
Q4 | $3.41M | Buy |
+34,610
| New | +$3.28M | 0.37% | 38 |
|
|
2017
Q3 | – | Sell |
-2,700
| Closed | -$300K | – | 828 |
|
|
2017
Q2 | $300K | Buy |
+2,700
| New | +$285K | 0.08% | 466 |
|
|
2015
Q4 | – | Sell |
-4,600
| Closed | -$282K | – | 1074 |
|
|
2015
Q3 | $282K | Buy |
+4,600
| New | +$322K | 0.02% | 889 |
|
Other funds holding DGX
Trexquant Investment's DGX Position: Q2 2025 in Review
Trexquant Investment sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 37,916 shares — an estimated $6.42M sold.
Trexquant Investment first reported a position in DGX in Q3 2015 and held it in 23 quarters. The position peaked at $10.5M in Q2 2024. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.
- Trexquant Investment reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
- Trexquant Investment sold 37,916 Quest Diagnostics shares in Q2 2025, an estimated $6.42M.
- Trexquant Investment first reported a position in Quest Diagnostics in Q3 2015 and held it in 23 quarters.
- Trexquant Investment's Quest Diagnostics position peaked at $10.5M in Q2 2024.
- 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.
Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.